Ocrelizumab, an anti-CD20 monoclonal antibody, targets mature B-cells. Almost 95% of the B-cell population has these antigenic epitopes after maturation and does not shed them, which is what makes it a potent marker for therapeutic purposes (cancer being a very common area of interest in this regard).
Read more about Ocrelizumab here: http://bit.ly/1JUBLqj
This drug is not good at all please do all the research on as many have died after taking this one . PLEASE BE CAREFUL
Thanks Lynne. I came here to caution readers also.
I’ve not heard about this ….. Can you provide a link to these claims you are making , as I’d be interested ?
This is completely untrue. If making such wild claims you should provide evidence
Also note that MS societys are also promoted this drug along with many more too. Billions has been made from MS patients who have all been exploted for financial gains
EXPLOITED excuse my spellings . Lots of are all being exploited with MS because they all know many are bedridden and unable to use a computer thats how sick it all is
I have been taking ocrelizumab for 5 years with no side effects and my ms stopped progressing after 6 months of treatment. The results have been amazing for me.